Canadian researchers from the University of Waterloo and the Sunnybrook Research Institute have developed an artificial intelligence (AI) technology to aid early detection of melanoma skin cancer.

The new AI tool uses machine-learning software to analyse skin lesion images and deliver objective data on common biomarkers of melanoma.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The cancer is reported to be deadly if detected too late, but can be treated more successfully when detected early.

Intended to decrease healthcare costs by minimising the number of unnecessary biopsies, the researchers trained the tool with numerous skin images and their corresponding eumelanin and haemoglobin levels.

Changes in the concentration and distribution of eumelanin, which is a chemical that imparts its colour to skin, and haemoglobin protein in red blood cells are considered as crucial indicators of the disease.

"This could be a very powerful tool for skin cancer clinical decision support."

The tool will also provide objective information on lesion characteristics to assist doctors in ruling out melanoma prior to any invasive action.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

University of Waterloo systems design engineering professor Alexander Wong said: “This could be a very powerful tool for skin cancer clinical decision support. The more interpretable information there is, the better the decisions are.”

The AI system is designed to add consistent, quantitative information to current appearance-based assessments by decoding levels of biomarker substances in lesions.

Developed by professor Wong in collaboration with his colleagues, the technology is expected to be available for doctors next year.


Image: Histopathologic image of malignant melanoma. Photo: courtesy of KGH/Wikipedia.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact